Your browser doesn't support javascript.
loading
Sequential therapies after atezolizumab plus bevacizumab or lenvatinib first-line treatments in hepatocellular carcinoma patients.
Persano, Mara; Rimini, Margherita; Tada, Toshifumi; Suda, Goki; Shimose, Shigeo; Kudo, Masatoshi; Cheon, Jaekyung; Finkelmeier, Fabian; Lim, Ho Yeong; Presa, José; Masi, Gianluca; Yoo, Changhoon; Lonardi, Sara; Tovoli, Francesco; Kumada, Takashi; Sakamoto, Naoya; Iwamoto, Hideki; Aoki, Tomoko; Chon, Hong Jae; Himmelsbach, Vera; Niizeki, Takashi; Montes, Margarida; Vivaldi, Caterina; Soldà, Caterina; Stefanini, Bernardo; Hiraoka, Atsushi; Sho, Takuya; Nishida, Naoshi; Steup, Christoph; Iavarone, Massimo; Di Costanzo, Giovanni; Marra, Fabio; Tamburini, Emiliano; Cabibbo, Giuseppe; Foschi, Francesco Giuseppe; Silletta, Marianna; Hirooka, Masashi; Kariyama, Kazuya; Tani, Joji; Atsukawa, Masanori; Takaguchi, Koichi; Itobayashi, Ei; Fukunishi, Shinya; Tsuji, Kunihiko; Ishikawa, Toru; Tajiri, Kazuto; Ochi, Hironori; Yasuda, Satoshi; Toyoda, Hidenori; Ogawa, Chikara.
Afiliação
  • Persano M; Medical Oncology, University and University Hospital of Cagliari, Italy. Electronic address: marapersano@alice.it.
  • Rimini M; Department of Oncology, Vita-Salute San Raffaele University, IRCCS San Raffaele Scientific Institute Hospital, Milan, Italy.
  • Tada T; Department of Internal Medicine, Japanese Red Cross Himeji Hospital, Himeji, Japan.
  • Suda G; Department of Gastroenterology and Hepatology, Graduate School of Medicine, Hokkaido University, North 15, West 7, Kita-ku, Sapporo, Hokkaido 060-8638, Japan.
  • Shimose S; Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Fukuoka 830-0011, Japan.
  • Kudo M; Department of Gastroenterology and Hepatology, Kindai University Faculty of Medicine, Osaka-Sayama, Osaka 589-8511, Japan.
  • Cheon J; Department of Medical Oncology, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, South Korea.
  • Finkelmeier F; Department of Internal Medicine 1, University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany.
  • Lim HY; Department of Medicine, Samsung Medical Center, School of Medicine, Sungkyunkwan University, Seoul, South Korea.
  • Presa J; Liver Unit-CHTMAD, Vila Real, Portugal.
  • Masi G; Unit of Medical Oncology 2, University Hospital of Pisa, Pisa, Italy; Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.
  • Yoo C; Department of Oncology, ASAN Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-gu, Seoul 05505, South Korea.
  • Lonardi S; Oncology Unit 1, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy.
  • Tovoli F; Division of Internal Medicine, Hepatobiliary and Immunoallergic Diseases, IRCCS Azienda Ospedaliero-Universitaria di Bologna, via Albertoni 15, Bologna, Italy.
  • Kumada T; Department of Nursing, Gifu Kyoritsu University, Ogaki, Japan.
  • Sakamoto N; Department of Gastroenterology and Hepatology, Graduate School of Medicine, Hokkaido University, North 15, West 7, Kita-ku, Sapporo, Hokkaido 060-8638, Japan.
  • Iwamoto H; Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Fukuoka 830-0011, Japan.
  • Aoki T; Department of Gastroenterology and Hepatology, Kindai University Faculty of Medicine, Osaka-Sayama, Osaka 589-8511, Japan.
  • Chon HJ; Department of Medical Oncology, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, South Korea.
  • Himmelsbach V; Department of Internal Medicine 1, University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany.
  • Niizeki T; Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Fukuoka 830-0011, Japan.
  • Montes M; Liver Unit-CHTMAD, Vila Real, Portugal.
  • Vivaldi C; Unit of Medical Oncology 2, University Hospital of Pisa, Pisa, Italy; Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.
  • Soldà C; Oncology Unit 1, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy.
  • Stefanini B; Division of Internal Medicine, Hepatobiliary and Immunoallergic Diseases, IRCCS Azienda Ospedaliero-Universitaria di Bologna, via Albertoni 15, Bologna, Italy.
  • Hiraoka A; Gastroenterology Center, Ehime Prefectural Central Hospital, Matsuyama, Japan.
  • Sho T; Department of Gastroenterology and Hepatology, Graduate School of Medicine, Hokkaido University, North 15, West 7, Kita-ku, Sapporo, Hokkaido 060-8638, Japan.
  • Nishida N; Department of Gastroenterology and Hepatology, Kindai University Faculty of Medicine, Osaka-Sayama, Osaka 589-8511, Japan.
  • Steup C; Department of Internal Medicine 1, University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany.
  • Iavarone M; Division of Gastroenterology and Hepatology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico di Milano, Milan, Italy.
  • Di Costanzo G; Department of Hepatology, Naples 80131, Italy.
  • Marra F; Dipartimento di Medicina Sperimentale e Clinica, Università di Firenze, Firenze, Italy.
  • Tamburini E; Department of Oncology and Palliative Care, Cardinale G Panico, Tricase City Hospital, Tricase, Italy.
  • Cabibbo G; Section of Gastroenterology & Hepatology, Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, PROMISE, University of Palermo, 90127 Palermo, Italy.
  • Foschi FG; Department of Internal Medicine, Ospedale per gli Infermi di Faenza, Faenza, Italy.
  • Silletta M; Division of Medical Oncology, Policlinico Universitario Campus Bio-Medico, Rome, Italy.
  • Hirooka M; Department of Gastroenterology and Metabology, Ehime University Graduate School of Medicine, Ehime, Japan.
  • Kariyama K; Department of Gastroenterology, Okayama City Hospital, Okayama, Japan.
  • Tani J; Department of Gastroenterology and Hepatology, Kagawa University, Kagawa, Japan.
  • Atsukawa M; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Nippon Medical School, Tokyo, Japan.
  • Takaguchi K; Department of Hepatology, Kagawa Prefectural Central Hospital, Takamatsu, Japan.
  • Itobayashi E; Department of Gastroenterology, Asahi General Hospital, Asahi, Japan.
  • Fukunishi S; Department of Gastroenterology, Osaka Medical and Pharmaceutical University, Osaka, Japan.
  • Tsuji K; Center of Gastroenterology, Teine Keijinkai Hospital, Sapporo, Japan.
  • Ishikawa T; Department of Gastroenterology, Saiseikai Niigata Hospital, Niigata, Japan.
  • Tajiri K; Department of Gastroenterology, Toyama University Hospital, Toyama, Japan.
  • Ochi H; Hepato-biliary Center, Japanese Red Cross Matsuyama Hospital, Matsuyama, Japan.
  • Yasuda S; Department of Gastroenterology and Hepatology, Ogaki Municipal Hospital, Ogaki, Japan.
  • Toyoda H; Department of Gastroenterology and Hepatology, Ogaki Municipal Hospital, Ogaki, Japan.
  • Ogawa C; Department of Gastroenterology, Japanese Red Cross Takamatsu Hospital, Takamatsu, Japan.
Eur J Cancer ; 189: 112933, 2023 08.
Article em En | MEDLINE | ID: mdl-37385069
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudo: Observational_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudo: Observational_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article